PRPS-related gout/PRPS superactivity (OMIM phenotype number 300661) is an XLR condition due to an activating variant in PRPS1, resulting in hyperuricemia with sensorineural hearing loss, neurologic issues gout, and NL (Jinnah et al., 2013). Here, MSMB is linked to hyperuricemia.